Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/4/19 → 1/31/23 |
Funding
- AbbVie Inc. (Prot #M16-045)
Prot #M16-045: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
- Paller, Amy (PD/PI)
- Silverberg, Jonathan I (Other)
Project: Research project